The Spectranetics Corporation, a leader in the medical device industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1984, the company has established itself as a pioneer in the development of innovative solutions for vascular intervention and cardiovascular procedures. Spectranetics is renowned for its advanced laser technology, particularly in the treatment of peripheral vascular disease and coronary artery disease. Their core products, including the CVX-300 and the Turbo-Elite laser systems, are distinguished by their precision and efficacy, setting new standards in minimally invasive procedures. With a strong market position, Spectranetics has achieved significant milestones, including FDA approvals and numerous clinical studies that validate the safety and effectiveness of its offerings. The company continues to drive advancements in the field, contributing to improved patient outcomes and enhanced procedural efficiency.
We don't have data for The Spectranetics Corporation, but we can show you information about their parent organization instead.
View parent company